Condition: Advanced Solid Tumors · Sponsor: Merck Sharp & Dohme LLC
This is a study evaluating the safety, pharmacokinetics, and efficacy of calderasib alone, and calderasib plus other combination therapies in participants with advanced solid tumors with identified kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Moffitt Cancer Center ( Site 0261) | Tampa, Florida, United States | Recruiting |
| START Midwest ( Site 0267) | Grand Rapids, Michigan, United States | Recruiting |
| John Theurer Cancer Center at Hackensack University Medical Center ( Site 0260) | Hackensack, New Jersey, United States | Recruiting |
| Laura and Isaac Perlmutter Cancer Center ( Site 0270) | New York, New York, United States | Completed |
| NEXT Virginia ( Site 0271) | Fairfax, Virginia, United States | Recruiting |
| MEDICAL COLLEGE OF WISCONSIN-Cancer Center Clinical Trials Office ( Site 0262) | Milwaukee, Wisconsin, United States | Recruiting |
| Instituto Alexander Fleming ( Site 0434) | Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina | Recruiting |
| Sanatorio Parque ( Site 0456) | Rosario, Santa Fe Province, Argentina | Recruiting |
| Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0438) | La Rioja, Argentina | Recruiting |
| Chris O'Brien Lifehouse ( Site 0002) | Camperdown, New South Wales, Australia | Recruiting |
| Liverpool Hospital-Medical Oncology ( Site 0001) | Liverpool, New South Wales, Australia | Recruiting |
| Westmead Hospital ( Site 0006) | Westmead, New South Wales, Australia | Recruiting |
+ 63 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05067283